Table 2 Baseline clinical characteristics of the included patients
| Â | AIR-CTO [13] | AVIO [14] | CTO-IVUS [15] | HOME DES IVUS [23] | ILUMIEN III [21] | iSIGHT [34] | IVUS-XPL [16] | Kala et al. [22] | Kim et al. [17] | Liu et al. [18] | RESET [24] | Tan et al. [19] | ULTIMATE [20] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients (n) | 115/115 | 142/142 | 201/201 | 105/105 | 136/153/142 | 50/51/49 | 700/700 | 105/96 | 269/274 | 167/169 | 662/912 | 61/62 | 724/724 |
Age (mean) | 67/66 | 64/64 | 61/61 | 59/60 | 66/66/67 | 59/60/59 | 64/64 | 57/59 | 63/64 | 65/65 | 61/63 | 77/76 | 65/66 |
Male (%) | 89/80 | 82/77 | 81/81 | 73/71 | 74/69/73 | 36/31/38 | 69/69 | 83/87 | 66/55 | 64/64 | 65/65 | 62/69 | 74/73 |
Current smokers (%) | 39/39 | 35/31 | 35/34 | 40/35 | 13/17/23 | 14/17/14 | 22/26 | 64/59 | 22/17 | 37/36 | 25/26 | 44/47 | 35/32 |
Hypertension (%) | 75/70 | 70/67 | 63/64 | 67/71 | 78/78/75 | 42/46/39 | 65/63 | 50/52 | 61/66 | 70/72 | 60/63 | 41/47 | 71/72 |
Dyslipidemia (%) | 22/28 | 70/77 | NR | 63/66 | 75/73/77 | 30/36/28 | 67/65 | NR | 61/62 | 38/38 | 61/56 | NR | 54/55 |
Diabetes (%) | 30/27 | 24/27 | 35/34 | 42/45 | 36/33/28 | 20/17/22 | 36/37 | 17/26 | 32/30 | 34/31 | 28/30 | 34/30 | 30/31 |
Previous MI (%) | 21/30 | NR | 8/8 | 37/32 | NR | 32/29/28 | 5/4 | 1/6 | 1/3 | 17/14 | 1/2 | 16/21 | 9/12 |
Previous PCI (%) | NR | NR | 15/16 | 17/14 | NR | NR | 11/10 | 4/4 | NR | 20/17 | 3/3 | NR | 17/20 |
Previous CABG (%) | NR | NR | 2/3 | 14/10 | NR | NR | 3/2 | 0/0 | NR | 1/1 | NR | NR | 1/1 |
LVEF (%) | 55/56 | 55/56 | 57/57 | NR | NR | NR | 63/62 | NR | 55/54 | 56/58 | NR | 55/53 | 61/60 |
Unstable angina (%) | 9/10 | 30/26 | NR | 43/39 | NR | NR | 35/32 | NR | 38/39 | 76/75 | NR | 70/66 | 67/64 |
Stable angina (%) | 71/76 | 70/64 | 100/100 | 38/40 | 35/34/35 | 18/22/21 | 51/51 | NR | 53/52 | 12/11 | 40/45 | 30/34 | 13/13 |
ACS (%) | 29/24 | 30/26 | NR | 72.60 | 36/33/36 | NR | 49/49 | NR | 47/49 | 86/87 | 45/55 | NR | 79/78 |